Stealth BioTherapeutics Corp MITO

$ 0.32 0.0%

Annual report 2021
added 12-23-2023

Stealth BioTherapeutics Corp Balance Sheet 2011-2024 | MITO

Annual Balance Sheet Stealth BioTherapeutics Corp

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-14.8 M	-34.5 M	111 M	57.8 M	-9.71 M	-	-	-	-	-
Long Term Debt	13.7 M	9 M	1.53 M	114 M	62 M	-	-	-	-	-	-
Long Term Debt Current	-	9 M	14.7 M	8.46 M	-	-	-	-	-	-	-
Total Non Current Liabilities	-	25.2 M	1.53 M	362 M	274 M	211 M	-	-	-	-	-
Total Current Liabilities	10.8 M	21 M	34 M	40.6 M	-	-	-	-	-	-	-
Total Liabilities	95.5 M	46.2 M	35.5 M	191 M	298 M	223 M	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-608 M	-555 M	-498 M	-426 M	-330 M	-247 M	-	-	-	-	-
Total Assets	50.2 M	35.8 M	52.7 M	15.5 M	7.15 M	13.3 M	-	-	-	-	-
Cash and Cash Equivalents	-	32.8 M	50.8 M	10.9 M	4.12 M	9.71 M	-	-	-	-	-
Book Value	-45.3 M	-10.4 M	17.3 M	-175 M	-291 M	-210 M	-	-	-	-	-
Total Shareholders Equity	-45.3 M	-10.4 M	17.3 M	-387 M	-291 M	-210 M	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Stealth BioTherapeutics Corp

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	13.7 M	-	-	-	9 M	8.98 M	-	-	1.53 M	-	-	-	10.3 M	-	-	-	12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	95.5 M	-	-	-	46.2 M	20.3 M	-	-	35.5 M	-	-	-	191 M	-	-	-	87.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-608 M	-	-	-	-555 M	-537 M	-	-	-498 M	-	-	-	-426 M	-	-	-	-330 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	50.2 M	-	-	-	35.8 M	22.5 M	-	-	52.7 M	-	-	-	15.5 M	-	-	-	7.15 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	47.1 M	-	-	-	32.8 M	19.9 M	-	-	50.8 M	37.2 M	-	-	10.9 M	-	-	-	4.12 M	-	-	-	9.71 M	-	-	-	13.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	-45.3 M	-	-	-	-10.4 M	2.27 M	-	-	17.3 M	-	-	-	-175 M	-	-	-	-79.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	-45.3 M	-	-	-	-10.4 M	2.27 M	-	-	17.3 M	3.7 M	-	-	-387 M	-	-	-	-291 M	-	-	-	-210 M	-	-	-	-151 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency